Quick Answer
VERTEX PHARMACEUTICALS INC / MA reported Total Assets of $25.64 billion for fiscal year 2025.
VERTEX PHARMACEUTICALS INC / MA Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $25.64B | +13.8% |
| 2024 | $22.53B | -0.9% |
| 2023 | $22.73B | +25.2% |
| 2022 | $18.15B | +35.1% |
| 2021 | $13.43B | +14.3% |
| 2020 | $11.75B | +41.3% |
| 2019 | $8.32B | +33.2% |
| 2018 | $6.25B | +76.1% |
| 2017 | $3.55B | +22.4% |
| 2016 | $2.90B | +15.9% |
| 2015 | $2.50B | +7.0% |
| 2014 | $2.33B | +0.7% |
| 2013 | $2.32B | -16.0% |
| 2012 | $2.76B | +25.2% |
| 2011 | $2.20B | +27.8% |
| 2010 | $1.73B | -11.8% |
| 2009 | $1.96B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.86B | +11.8% | +3.4% |
| June 30, 2025 | $24.04B | +19.4% | +5.1% |
| March 31, 2025 | $22.88B | -4.3% | +1.5% |
| December 31, 2024 | $22.53B | -0.9% | +1.3% |
| September 30, 2024 | $22.24B | +2.4% | +10.5% |
| June 30, 2024 | $20.13B | -1.1% | -15.8% |
| March 31, 2024 | $23.92B | +26.1% | +5.2% |
| December 31, 2023 | $22.73B | +25.2% | +4.6% |
- VERTEX PHARMACEUTICALS INC / MA showed an increase of +13.8% in Total Assets compared to the prior fiscal year.
- Over the 2009–2025 period, VERTEX PHARMACEUTICALS INC / MA’s total assets has grown by 1211.3% (from $1.96 billion to $25.64 billion).
- The most recent figure is from VERTEX PHARMACEUTICALS INC / MA’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: